Cargando…
Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Hypoglycemia
A relatively recent addition to the arsenal of antidiabetic drugs used for the treatment of type 2 diabetes mellitus (T2DM) has been the “incretin mimetics,” a group of drugs that work on the glucagon-like peptide-1 (GLP-1) receptor and enhance insulin secretion from the pancreatic β-cells in a gluc...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527576/ https://www.ncbi.nlm.nih.gov/pubmed/34690504 http://dx.doi.org/10.1177/11795514211051697 |